[Correction of high myopia with anterior chamber angle-supported phakic intraocular lenses--own results]

To evaluate the early results: predictability, efficacy and safety of implanting new model of anterior chamber IOL for high myopia.

ICARE myopia lens (Corneal) was implanted in 20 eyes of 12 patients with preoperative myopia that ranged from -10 D to 23.5 D. Mean patient age was 32.3 years. The follow-up period was 6 months. The desired outcome was emmetropia.

Eighteen eyes (85%) had a postoperative refraction at the last follow-up examination in a range +/- 1.0 D of emmetropia. The postoperative refraction remained stable during the entire follow-up period. Mean visual acuity before surgery, corrected with spectacle improved from 0.5 to 0.68 postoperatively without glasses in 3 months time. There was no loss in visual acuity after operation. We didn't encounter major complications. Mean endothelial cell density reduction was 3.2% in our 3 months study.

Implantation of ICARE myopia lens to correct high myopia resulted in a stable and predictable refractive outcome. Further investigation is necessary to evaluate long-term stability and safety of this procedure.